Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a "Patient-Specific" Approach https://t.co/eL0eoQcGdh https://t.co/doMTwArzZM
Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a "Patient-Specific" Approach.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2023 – May 2024Where it's discussed
-
X / Twitter8 posts
-
YouTube2 videos
-
Facebook2 posts
AI synopsis
What people are saying
Discussions highlight the importance of the multiomics approach in identifying novel biomarkers like NAMPT and SETMAR, with phrases such as 'significant breakthrough' and 'potential game changer,' emphasizing how the words and tone reflect curiosity and recognition of the research's impact. References to methodology and future applications demonstrate moderate engagement and interest, aligning with the overall positive stance.
Most discussions acknowledge the significance of the study, with some expressing enthusiasm about its findings and potential for future research.
The posts demonstrate moderate curiosity, referencing specific molecular pathways and biomarkers, indicating a genuine interest in the details of the research.
Several social discussions delve into the methodology and implications, showing some level of deep engagement, though others are more general acknowledgments.
Many participants believe the study could influence future diagnostics and treatments for childhood nephrotic syndrome, highlighting perceived high impact.
Abstract in brief
- The study used a unique patient-specific multiomics approach to analyze plasma proteomics and metabolomics data from children with childhood nephrotic syndrome, focusing on identifying biomarkers for steroid resistance (SRNS) versus steroid sensitivity (SSNS).
- It involved analyzing samples collected before glucocorticoid treatment to avoid confounding effects and combined data to identify altered molecular pathways associated with SRNS, such as nicotinate/nicotinamide and butanoate metabolism.
- The research uncovered novel molecular targets, like NAMPT and SETMAR, that were upregulated in SRNS, and validated these findings through immunoblotting, demonstrating the effectiveness of a combined, patient-specific bioinformatics approach in discovering potential biomarkers.
Top posts
Most liked on X and Bluesky@KIReports @jradnephro @SumitMohanMD @greeneema @anna_francis1 @StephenPastan @sophia_kidney @ghobby @AgarwalRajivMD @deniise_am @DrSumanBehera @MisraMD @waseemwahood @ETakahashiMD @UMNkidney ➡️ Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a “Patient-Specific” Approach https://t.co/hVE4GQH5vb https://t.co/pBPabQ41z3
Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a “Patient-Specific” Approach https://t.co/EdcUVjJEJb
RT @thePNRC: Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a "Patie…
RT @ISNkidneycare: @KIReports @jradnephro @SumitMohanMD @greeneema @anna_francis1 @StephenPastan @sophia_kidney @ghobby @AgarwalRajivMD @de…
RT @ISNkidneycare: @KIReports @jradnephro @SumitMohanMD @greeneema @anna_francis1 @StephenPastan @sophia_kidney @ghobby @AgarwalRajivMD @de…
All mentions
Autoantibodies Targeting Nephrin in Minimal Change Disease Explained
Astrid Weins discusses the role of anti-nephrin antibodies in minimal change disease and highlights recent research supporting an autoimmune cause for nephrotic syndrome, including potential biomarkers and future…
Autoimmune Role of Nephrin Antibodies in Minimal Change Disease
Dr Astrid Weins discusses nephropathology and her research on anti-nephrin antibodies in minimal change disease, highlighting potential autoimmune causes and advancements in understanding nephrotic syndrome.
RT @thePNRC: Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a "Patie…
RT @thePNRC: Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a "Patie…
Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a "Patient-Specific" Approach https://t.co/eL0eoQcGdh https://t.co/doMTwArzZM
New NUTRITION Research Available. Click Here to Access Article(s): https://t.co/1GzLTWc9FJ
RT @ISNkidneycare: @KIReports @jradnephro @SumitMohanMD @greeneema @anna_francis1 @StephenPastan @sophia_kidney @ghobby @AgarwalRajivMD @de…
RT @ISNkidneycare: @KIReports @jradnephro @SumitMohanMD @greeneema @anna_francis1 @StephenPastan @sophia_kidney @ghobby @AgarwalRajivMD @de…
@KIReports @jradnephro @SumitMohanMD @greeneema @anna_francis1 @StephenPastan @sophia_kidney @ghobby @AgarwalRajivMD @deniise_am @DrSumanBehera @MisraMD @waseemwahood @ETakahashiMD @UMNkidney ➡️ Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a “Patient-Specific” Approach https://t.co/hVE4GQH5vb https://t.co/pBPabQ41z3
Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a “Patient-Specific” Approach https://t.co/EdcUVjJEJb
PC
IN
K
FL
SA
A
SL
AR